PET‐measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Andrew McVea und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, University of Wisconsin - Madison School of Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Down Syndrome, Amyloid beta-Peptides, Positron-Emission Tomography, Alzheimer Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
INTRODUCTION Individuals with Down syndrome (DS) have a high prevalence of Alzheimer's disease (AD) and reveal an earlier age of amyloid beta (Aβ) onset compared to sporadic AD. Differences in amyloid accumulation rates between DS and sporadic AD populations have not been established. METHODS Participants with ≥ 3 [C‐11]PiB scans (spanning > 6 years) and transitioning to Aβ+ were included, resulting in 20 DS and 23 neurotypical (NT) participants. Amyloid accumulation was compared using global standardized uptake value ratio (SUVR) for Aβ deposition, with individual growth rates ( r ) estimated using the logistic growth model (). RESULTS The average growth rate in the DS cohort was 0.28 (0.08)/year versus 0.20 (0.08)/year for NT (), an increase of 40%. DISCUSSION Using individual longitudinal analyses, accelerated amyloid accumulation in DS is observed, This has important considerations for informing treatment trial design and monitoring beta‐amyloid changes in future AD studies involving individuals with DS. Highlights Aβ accumulation rate was estimated using a logistic growth model. There was no overlap in the age of amyloid positivity between DS and NT cohorts. Participants with DS accumulate amyloid 40% faster than those with sporadic AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Physics, University of Wisconsin - Madison School of Public Health, Madison, Wisconsin, USA.
- Waisman Center, University of Wisconsin - Madison School of Public Health, Madison, Wisconsin, USA.
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin - Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Neurology, Columbia University, New York, New York, USA.
- Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.
ORCID-Profile: Andrew McVea
Förderung
- NIA NIH HHS
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute on Aging
Zitieren
APA
McVea, A., DiFilippo, A., McLachlan, M., Betcher, B., Zammit, M., Betthauser, T. J., Converse, A., Murali, D., Stone, C., Hartley, S., Johnson, S., Tudorascu, D. L., Laymon, C. M., Cohen, A. D., Minhas, D., Luo, W., Mathis, C., Lao, P. J., Ances, B., …, & ABC‐DS investigators (2025). PET‐measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70357
Vancouver
McVea A, DiFilippo A, McLachlan M, Betcher B, Zammit M, Betthauser TJ, et al. PET‐measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70357
BibTeX
@article{McVea2025,
author = {McVea, Andrew and DiFilippo, Alexandra and McLachlan, Max and Betcher, Brecca and Zammit, Matthew and Betthauser, Tobey J and Converse, Alexander and Murali, Dhanabalan and Stone, Charles and Hartley, Sigan and Johnson, Sterling and Tudorascu, Dana L and Laymon, Charles M and Cohen, Ann D and Minhas, Davneet and Luo, Weiquan and Mathis, Chester and Lao, Patrick J and Ances, Beau and Zaman, Shahid and Mapstone, Mark and Head, Elizabeth and Handen, Benjamin L and Christian, Bradley T and ABC‐DS investigators, ABC‐DS investigators},
title = {PET‐measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70357}
}
EUVIMED